![]() |
市场调查报告书
商品编码
1467799
下腔静脉过滤器市场依产品、材料、应用(治疗静脉血栓栓塞、预防肺栓塞等)、最终使用者(医院、门诊手术中心等)及地区2024-2032年Inferior Vena Cava Filter Market by Product, Material, Application (Treatment Venous Thromboembolism, Prevent Pulmonary Embolism, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Region 2024-2032 |
IMARC Group年,全球下腔静脉(IVC)过滤器市场规模达7.17亿美元。 。深部静脉血栓(DVT)和肺栓塞(PE)的盛行率不断上升,消费者对疾病风险和后果的认识不断提高,以及对微创外科手术的日益偏好是推动市场的一些主要因素。
下腔静脉(IVC)过滤器是一种医疗器械,旨在防止血栓从下半身迁移到肺部,降低肺栓塞的风险。它是一种由金属或合成材料製成的小型笼状结构。它插入下腔静脉,将去氧血液从下半身输送到心臟。它透过捕获血块并防止它们到达肺部来充当物理屏障。
目前,血栓高风险患者越来越多地采用 IVC 过滤器,这促进了市场的成长。除此之外,由于医疗保健提供者有利的报销政策,IVC 过滤器的使用率不断上升正在推动市场的成长。此外,由于老年人更容易发生静脉血栓栓塞,体外受精过滤器的使用越来越多,这也促进了市场的成长。此外,由于世界各地群众对微创外科手术的日益偏好,对 IVC 过滤器的需求不断增长,这对市场产生了积极影响。此外,由于医疗保健基础设施的改善,医疗解决方案的采用不断增加,正在加强市场的成长。
深部静脉血栓 (DVT) 和肺栓塞 (PE) 盛行率上升
由于全球深部静脉栓塞 (DVT) 和肺栓塞 (PE) 的盛行率不断增加,对 IVC 过滤器的需求不断增加。当深层静脉(通常是腿部)形成血块时,通常会发生深部静脉血栓。此外,如果这些血栓脱落并进入肺部,就会导致危及生命的疾病,称为肺栓塞。由于久坐的生活方式、肥胖、身体活动不当和其他与生活方式相关的问题,人们越来越多地面临 DVT 和 PE 病例。此外,老年族群发生 DVT 的机会增加。此外,医疗保健提供者越来越多地采用 IVC 过滤器作为高风险患者的预防措施,以减少 PE 的发生及其相关的发病率和死亡率。
提高消费者对疾病风险和后果的认识
由于医疗保健专业人员和一般大众对 DVT 和 PE 的风险和后果的认识不断提高,对 IVC 过滤器的需求增加。
各国管理机构正在透过宣传、组织运动和采取教育措施来鼓励采用下腔静脉过滤器,以预防静脉血栓栓塞。此外,诊断能力的快速进步可以更准确、更及时地检测 DVT 和 PE 病例,从而改善患者的治疗效果。此外,早期诊断使医疗保健专业人员能够识别可以从 IVC 过滤器放置中受益的个体。下腔静脉过滤器的使用不断增加,为预防肺栓塞提供可靠且有效的解决方案,有助于市场的成长。
IVC 过滤技术的进步
各家製造商正在迅速推进 IVC 过滤技术,以提高产品的安全性和功效。此外,越来越多地引入可回收的下腔静脉过滤器,一旦肺栓塞的风险消除,就可以将其移除。这些可回收的过滤器为医疗保健专业人员提供了更多的灵活性和有效管理患者的选择,这带来了积极的市场前景。此外,过滤器设计和材料的各种技术进步有助于增强生物相容性并降低不良反应和长期併发症的风险。除此之外,由于 IVC 过滤器的有效性增强,适用于适当病例的采用率不断上升。
The global inferior vena cava (IVC) filter market size reached US$ 717.0 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,371.1 Million by 2032, exhibiting a growth rate (CAGR) of 7.25% during 2024-2032. The growing prevalence of deep vein thrombosis (DVT) and pulmonary embolism (PE), rising consumer awareness about the risks and consequences of diseases, and increasing preference for minimally invasive surgical procedures are some of the major factors propelling the market.
An inferior vena cava (IVC) filter is a medical device that is designed to prevent the migration of blood clots from the lower body to the lungs and reduce the risk of pulmonary embolism. It is a small and cage-like structure that is manufactured from metal or synthetic materials. It is inserted into the inferior vena cava vein that carries deoxygenated blood from the lower body to the heart. It acts as a physical barrier by trapping blood clots and preventing them from reaching the lungs.
At present, the increasing adoption of IVC filters among patients who are at high risk of developing blood clots is contributing to the growth of the market. Apart from this, the rising utilization of IVC filters on account of favorable reimbursement policies by healthcare providers is propelling the growth of the market. Moreover, the increasing adoption of IVF filters among the geriatric population, as they are more prone to venous thromboembolism, is bolstering the growth of the market. Additionally, the growing demand for IVC filters due to the increasing preference for minimally invasive surgical procedures among the masses around the world is positively influencing the market. Furthermore, the rising adoption of medical treatment solutions due to the improving healthcare infrastructure is strengthening the growth of the market.
Rising prevalence of deep vein thrombosis (DVT) and pulmonary embolism (PE)
There is a rise in the demand for IVC filters due to the increasing prevalence of deep vein thrombosis (DVT) and pulmonary embolism (PE) among the masses across the globe. Deep vein thrombosis usually occurs when blood clots form in deep veins, often in the legs. Moreover, if these clots break loose and travel to the lungs, then they can cause a life-threatening condition known as pulmonary embolism. People are increasingly facing DVT and PE cases due to sedentary lifestyles, obesity, improper physical activity, and other lifestyle-related issues. Additionally, there is an increased chance of the development of DVT among the geriatric aging population. Furthermore, healthcare providers are increasingly adopting IVC filters as a preventive measure for high-risk patients to reduce the occurrence of PE and its associated morbidity and mortality.
Increasing consumer awareness about the risks and consequences of diseases
There is an increase in the demand for IVC filters due to the rising awareness about the risks and consequences of DVT and PE among healthcare professionals and the general population.
Governing agencies of various countries are encouraging the adoption of IVC filters by spreading awareness, organizing campaigns, and taking educational initiatives to focus on venous thromboembolism prevention. Moreover, rapid advancements in diagnostic capabilities allow more accurate and timely detection of DVT and PE cases that enhances patient outcomes. In addition, early diagnosis allows healthcare professionals to identify individuals who could benefit from IVC filter placement. The rising utilization of IVC filters to provide a reliable and effective solution for preventing pulmonary embolism is contributing to the growth of the market.
Advancements in IVC filter technology
Various manufacturers are rapidly advancing IVC filter technology to provide improved safety and efficacy of the product. In addition, the rising introduction of retrievable IVC filters, which can be removed once the risk of pulmonary embolism has settled. These retrievable filters provide healthcare professionals with more flexibility and options for managing patients effectively, which is offering a positive market outlook. Additionally, various technological advancements in filter design and materials assist in enhancing biocompatibility and reducing the risk of adverse reactions and long-term complications. Apart from this, the rising adoption rates of IVC filters for appropriate cases due to their enhanced effectiveness.
IMARC Group provides an analysis of the key trends in each segment of the global inferior vena cava (IVC) filter market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product, material, application and end user.
Retrievable IVC Filter
Permanent IVC Filter
Retrievable IVC filter represents the largest market segment
The report has provided a detailed breakup and analysis of the market based on the product. This includes retrievable IVC filter and permanent IVC filter. According to the report, retrievable IVC filter represented the largest segment.
Retrievable IVC filters are medical devices that are designed to be implanted temporarily in patients at high risk of pulmonary embolism. They can be removed once the risk of clot migration has subsided or when the condition of the patient is improved. In addition, the retrievable IVC filter placement procedure is minimally invasive and typically performed by an interventional radiologist. The rising adoption of retrievable IVC filters, as they offer flexibility to healthcare providers in treatment options, is propelling the growth of the market.
Non-Ferromagnetic Material
Ferromagnetic Materials
Non-ferromagnetic material accounts for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the material. This includes non-ferromagnetic material and ferromagnetic materials. According to the report, non-ferromagnetic material represented the largest segment.
Non-ferromagnetic materials are those that do not contain iron and do not exhibit magnetic properties. They are used to construct filter devices and offer enhanced biocompatibility. They can withstand the physiological environment within the human body without causing adverse reactions. In addition, they are widely used in medical settings where the presence of magnetic materials could interfere with imaging techniques, such as magnetic resonance imaging (MRI). Non-ferromagnetic materials are utilized in the construction of IVC filters that allow patients to undergo MRI scans without any concerns about potential complications or distortions in the images.
Treatment Venous Thromboembolism (VTE)
Prevent Pulmonary Embolism (PE)
Others
Treatment venous thromboembolism (VTE) holds the biggest market share
The report has provided a detailed breakup and analysis of the market based on the application. This includes treatment venous thromboembolism (VTE), prevent pulmonary embolism (PE), and others. According to the report, treatment venous thromboembolism (VTE) represented the largest segment.
In the treatment venous thromboembolism (VTE), the IVC filters are placed in the inferior vena cava that carries deoxygenated blood from the lower body to the heart, to trap blood clots and prevent their migration to the lungs. They assist in reducing the risk of pulmonary embolism and its potential consequences in the body. They also provide an additional layer of protection against blood clot migration in high-risk patients. In line with this, VTE treatment provides enhanced patient outcomes and improved overall safety in managing VTE cases.
Hospitals
Ambulatory Surgical Centers (ASCs)
Others
Hospitals dominate the market share
The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, ambulatory surgical centers (ASCs), and others. According to the report, hospitals represented the largest segment.
Hospitals are the primary end-users of IVC filters, as they provide enhanced treatment options to patients with various medical conditions, such as those at high risk of venous thromboembolism (VTE). In hospitals, IVC filters are widely utilized in patients undergoing surgical procedures or those admitted for trauma or critical care, and individuals with known risk factors for developing deep vein thrombosis (DVT) or pulmonary embolism (PE). In addition, hospitals are equipped with advanced medical technologies and experienced healthcare professionals that benefit in managing VTE cases effectively. Interventional radiologists or vascular surgeons often perform the minimally invasive procedure of inserting IVC filters in hospital settings.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America exhibits a clear dominance, accounting for the largest inferior vena cava (IVC) filter market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America held the biggest market share due to the presence of well-established healthcare infrastructure and facilities. In addition, the rising prevalence of obesity among individuals is contributing to the growth of the market in the region. Apart from this, the increasing utilization of IVC filters as a preventive measure among patients is supporting the growth of the market. In line with this, the rising adoption of IVC filers due to favorable regulatory framework and reimbursement policies is bolstering the growth of the market in the North America region.
Key players in the industry are investing in research and development (R&D) activities to improve the design, materials, and safety features of IVC filters. In line with this, they are developing retrievable filters, enhancing the biocompatibility of products, and exploring innovative filter designs to reduce complications and enhance patient outcomes. Apart from this, many companies are launching new IVC filter products or introducing upgraded versions of their existing products to address specific clinical needs. They are also conducting clinical trials and research studies to gather more data on the safety and efficacy of their IVC filter products. In addition, major manufacturers are working to address safety concerns related to IVC filters, such as filter migration, fracture, and perforation.
ALN Implants Chirurgicaux
Argon Medical Devices Inc.
B. Braun Melsungen AG
Becton Dickinson and Company
Braile Biomedica
Cook Group Incorporated
In January 2020, Argon Medical Devices Inc launched single-loop and triple-loop retrieval kits for sale in the U.S. for percutaneous removal of retrievable inferior vena cava (IVC) filters that are no longer medically required, via a jugular approach.
In May 2022, Argon Medical announced a partnership agreement with Terumo India, a global leader in medical technology, to make their products available in India and provide end to end solutions for interventional radiology, vascular surgery, interventional cardiology, and clinical oncology.
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report